Expression of wild-type, but not mutant, loricrin causes programmed cell death in HaCaT keratinocytes

Journal of Dermatology

Volumn 37, Issue 11, 2010, Pages 956-964

  Yoneda, Kozo ^a   Demitsu, Toshio ^b   Manabe, Motomu ^c   Igarashi, Junsuke ^d   Kosaka, Hiroaki ^d   Inagaki, Nobuya ^e   Takahashi, Hidetoshi ^f   Kon, Atsushi ^g   Kakurai, Maki ^b   Kubota, Yasuo ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c AKITA UNIVERSITY   (Japan)

^d KAGAWA UNIVERSITY   (Japan)

^e KYOTO UNIVERSITY   (Japan)

^f ASAHIKAWA MEDICAL COLLEGE   (Japan)

^g HIROSAKI UNIVERSITY   (Japan)

Author keywords

caspase 14; cornified cell envelope; loricrin; programmed cell death

Indexed keywords

CASPASE 14; LORICRIN; MUTANT PROTEIN;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; KERATINOCYTE; PROTEIN EXPRESSION; WILD TYPE;

APOPTOSIS; CASPASE 14; CELL LINE; ENZYME ACTIVATION; EPIDERMIS; GENE EXPRESSION; HUMANS; KERATINOCYTES; MEMBRANE PROTEINS; MUTATION; TRANSFECTION;

EID: 78349242882     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2010.00932.x     Document Type: Article

References (31)

1. Yoneda K, Hohl D, McBride OW, et al. The human loricrin gene. J Biol Chem 1992; 267: 18060-18066.
2. Yoneda K, McBride OW, Korge BP, Kim IG, Steinert PM,. The cornified cell envelope: loricrin and transglutaminases. J Dermatol 1992; 19: 761-764.
3. Yoneda K, Steinert PM,. Overexpression of human loricrin in transgenic mice produces a normal phenotype. Proc Natl Acad Sci USA 1993; 90: 10754-10758.
4. Ishida-Yamamoto A, Hohl D, Roop DR, Iizuka H, Eady RA,. Loricrin immunoreactivity in human skin: localization to specific granules (L-granules) in acrosyringia. Arch Dermatol Res 1993; 285: 491-498.
5. Ishida-Yamamoto A,. Loricrin keratoderma: a novel disease entity characterized by nuclear accumulation of mutant loricrin. J Dermatol Sci 2003; 31: 3-8.
6. Bickenbach JR, Greer JM, Bundman DS, Rothnagel JA, Roop DR,. Loricrin expression is coordinated with other epidermal proteins and the appearance of lipid lamellar granules in development. J Invest Dermatol 1995; 104: 405-410.
7. Maestrini E, Monaco AP, McGrath JA, et al. A molecular defect in loricrin, the major component of the cornified cell envelope, underlies Vohwinkel's syndrome. Nat Genet 1996; 13: 70-77.
8. Korge BP, Ishida-Yamamoto A, Punter C, et al. Loricrin mutation in Vohwinkel's keratoderma is unique to the variant with ichthyosis. J Invest Dermatol 1997; 109: 604-610.
9. Armstrong DK, McKenna KE, Hughes AE,. A novel insertional mutation in loricrin in Vohwinkel's Keratoderma. J Invest Dermatol 1998; 111: 702-704.
10. Takahashi H, Ishida-Yamamoto A, Kishi A, Ohara K, Iizuka H,. Loricrin gene mutation in a Japanese patient of Vohwinkel's syndrome. J Dermatol Sci 1999; 19: 44-47.
11. Matsumoto K, Muto M, Seki S, et al. Loricrin keratoderma: a cause of congenital ichthyosiform erythroderma and collodion baby. Br J Dermatol 2001; 145: 657-660.
12. O'Driscoll J, Muston GC, McGrath JA, Lam HM, Ashworth J, Christiano AM,. A recurrent mutation in the loricrin gene underlies the ichthyotic variant of Vohwinkel syndrome. Clin Exp Dermatol 2002; 27: 243-246.
13. Gedicke MM, Traupe H, Fischer B, Tinschert S, Hennies HC,. Towards characterization of palmoplantar keratoderma caused by gain-of-function mutation in loricrin: analysis of a family and review of the literature. Br J Dermatol 2006; 154: 167-171.
14. Ishida-Yamamoto A, McGrath JA, Lam H, Iizuka H, Friedman RA, Christiano AM,. The molecular pathology of progressive symmetric erythrokeratoderma: a frameshift mutation in the loricrin gene and perturbations in the cornified cell envelope. Am J Hum Genet 1997; 61: 581-589.
15. Ishida-Yamamoto A, Takahashi H, Iizuka H,. Loricrin and human skin diseases: molecular basis of loricrin keratodermas. Histol Histopathol 1998; 13: 819-826.
16. Ishida-Yamamoto A, Takahashi H, Presland RB, Dale BA, Iizuka H,. Translocation of profilaggrin N-terminal domain into keratinocyte nuclei with fragmented DNA in normal human skin and loricrin keratoderma. Lab Invest 1998; 78: 1245-1253.
17. Song S, Shen C, Song G, et al. A novel c.545-546insG mutation in the loricrin gene correlates with a heterogeneous phenotype of loricrin keratoderma. Br J Dermatol 2008; 159: 714-719.
18. Yoneda K, Furukawa T, Zheng YJ, et al. An autocrine/paracrine loop linking keratin 14 aggregates to tumor necrosis factor alpha-mediated cytotoxicity in a keratinocyte model of epidermolysis bullosa simplex. J Biol Chem 2004; 279: 7296-7303.
19. Inoue T, Yoneda K, Manabe M, Demitsu T,. Spontaneous regression of merkel cell carcinoma: a comparative study of TUNEL index and tumor-infiltrating lymphocytes between spontaneous regression and non-regression group. J Dermatol Sci 2000; 24: 203-211.
20. Yoneda K, Fujimoto T, Imamura S, Ogawa K,. Distribution of fodrin in the keratinocyte in vivo and in vitro. J Invest Dermatol 1990; 94: 724-729.
21. Ishida-Yamamoto A, Kato H, Kiyama H, et al. Mutant loricrin is not crosslinked into the cornified cell envelope but is translocated into the nucleus in loricrin keratoderma. J Invest Dermatol 2000; 115: 1088-1094.
22. DiColandrea T, Karashima T, Maatta A, Watt FM,. Subcellular distribution of envoplakin and periplakin: insights into their role as precursors of the epidermal cornified envelope. J Cell Biol 2000; 151: 573-586.
23. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE,. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 1988; 106: 761-771.
24. Sitailo LA, Jerome-Morais A, Denning MF,. Mcl-1 functions as major epidermal survival protein required for proper kertinocyte differentiation. J Invest Dermatol 2009; 129: 1351-1360.
25. Smith FJ, Irvine AD, Terron-Kwiatkowski A, et al. Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris. Nat Genet 2006; 38: 337-342.
26. Palmer CN, Irvine AD, Terron-Kwiatkowski A, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006; 38: 441-446.
27. Dale BA, Presland RB, Lewis SP, Underwood RA, Fleckman P,. Transient expression of epidermal filaggrin in cultured cells causes collapse of intermediate filament networks with alteration of cell shape and nuclear integrity. J Invest Dermatol 1997; 108: 179-187.
28. Kuechle MK, Presland RB, Lewis SP, Fleckman P, Dale BA,. Inducible expression of filaggrin increases keratinocyte susceptibility to apoptotic cell death. Cell Death Differ 2000; 7: 566-573.
29. Takahashi H, Komatsu N, Ibe M, Ishida-Yamamoto A, Hashimoto Y, Iizuka H,. Cystatin A suppresses ultraviolet B-induced apoptosis of keratinocytes. J Dermatol Sci 2007; 46: 179-187.
30. Presland RB, Coulombe PA, Eckert RL, Mao-Qiang M, Feingold KR, Elias PM,. Barrier function in transgenic mice overexpressing K16, involucrin, and filaggrin in the suprabasal epidermis. J Invest Dermatol 2004; 123: 603-606.
31. Presland RB, Kuechle MK, Lewis SP, Fleckman P, Dale BA,. Regulated expression of human filaggrin in keratinocytes results in cytoskeletal disruption, loss of cell-cell adhesion, and cell cycle arrest. Exp Cell Res 2001; 270: 199-213.